Table 4. Anthropometric and clinical data of patients demonstrating improved glycemic control at baseline and after 3 months (IGC population).

	Visit	IGC 1	IGC 2	IGC 3	IGC 4	IGC 5	IGC 6
Sex		m	m	m	f	f	m
Age (years)		62	58	67	55	75	66
BMI (kg/m2)	Baseline	34.60	31.41	25.22	46.23	29.05	35.92
	Visit 2	33.56	28.29	24.90	43.97	27.99	35.92
Waist-hip ratio	Baseline	0.94	1.04	0.93	0.92	0.90	1.08
	Visit 2	0.95	1.01	0.97	0.93	0.89	1.06
RR systolic (mmHg)	Baseline	180	144	122	156	148	153
	Visit 2	152	135	122	145	125	156
RR diastolic (mmHg)	Baseline	96	81	85	88	71	77
	Visit 2	87	73	95	89	68	81
Triglycerides (mM)	Baseline	1.71	1.46	1.00	2.85	1.37	1.77
	Visit 2	1.16	0.54	0.97	2.23	1.06	1.82
Total cholesterol (mM)	Baseline	5.54	5.47	4.57	5.54	4.18	2.90
	Visit 2	5.42	4.39	4.47	4.66	3.32	2.82
LDL-C (mM)	Baseline	3.91	3.71	2.94	3.32	2.66	1.41
	Visit 2	4.01	3.03	2.95	2.75	1.93	1.33
HDL-C (mM)	Baseline	0.95	1.37	1.35	1.49	1.09	0.98
	Visit 2	0.99	1.47	1.37	1.40	1.07	1.02
HbA1c (%)	Baseline	9.1	7.5	8.2	13.5	8.3	8.4
	Visit 2	7.8	5.9	6.9	9.9	7.5	7.6

HbA_1c, glycosylated haemoglobin; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; m, male; f, female, Visit 2: three month after baseline